PROFILING OF EGFR POSITIVE MUTATION LUNG ADENOCARCINOMA IN A MALAYSIAN TERTIARY CENTRE: A PRELIMINARY DATA

被引：0
|
作者：
Esa, N. Y. Mohd [1 ]
Musa, A. N. [1 ]
Isa, M. R. [1 ]
Nordin, N. [1 ]
Zim, M. A. Mohd [1 ]
Ismail, A. I. [1 ]
机构：
[1] Univ Teknol MARA UiTM, Internal Med, Sungai Buloh, Malaysia
来源：
RESPIROLOGY | 2016年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
APSR6-0608
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [41] EGFR and BRAF Mutation Detection in FFPE Samples of Lung Adenocarcinoma
    Yang Yang
    Zhang Hang
    Shen Xiaoyan
    Yu Lixia
    Liu Baorui
    Wang Lifeng
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1493 - S1494
  • [42] Molecular Profiling of EGFR-Positive NSCLC with Secondary T790M Resistance Mutation and Tertiary Transformation into Small-Cell Lung Cancer
    Faehling, Martin
    Volckmar, Anna-Lena
    Stenzinger, Albrecht
    Schwenk, Birgit
    Kramberg, Sebastian
    Straeter, Joern
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1259 - S1260
  • [43] Observation on the clinical efficacy and side effects of EGFR-TKI +/- chemotherapy in the treatment of EGFR mutation-positive advanced lung adenocarcinoma
    Zheng, Jianping
    Cui, Tongjian
    Li, Ting
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [44] Observation on the clinical efficacy and side effects of EGFR-TKI ± chemotherapy in the treatment of EGFR mutation-positive advanced lung adenocarcinoma
    Zheng, Jianping
    Cui, Tongjian
    Li, Ting
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [45] KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma
    Xu, Hui
    Shao, Chuan
    ONCOTARGETS AND THERAPY, 2020, 13 : 8317 - 8321
  • [46] EGFR Therapy in ASCL1 Positive Lung Adenocarcinoma
    Kosari, F.
    Bhinge, K.
    Peikert, T.
    Mansfield, A.
    Aubry, M.
    Yang, L.
    Muppa, P.
    Kovtun, I.
    Vasmatzis, G.
    Murphy, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S586 - S586
  • [47] Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patient
    Hecimovic, Ana
    Dugac, Andrea Vukic
    Makek, Mateja Jankovic
    Cikes, Maja
    Samarzija, Miroslav
    Jakopovic, Marko
    MONALDI ARCHIVES FOR CHEST DISEASE, 2019, 89 (02) : 9 - 11
  • [48] Analysis of EGFR mutation status in blood and CSF in lung adenocarcinoma patients with EGFR mutation and CNS metastasis by ddPCR
    Sen, Y.
    Wang, Q.
    ANNALS OF ONCOLOGY, 2017, 28 : 183 - 183
  • [49] Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR Mutation-Positive Lung Adenocarcinoma: A Review
    Koehler, Jens
    Schuler, Martin
    ONKOLOGIE, 2013, 36 (09): : 510 - 518
  • [50] Tumor Mutation Signature Reveals the Risk Factors of Lung Adenocarcinoma with EGFR or KRAS Mutation
    Wang, Jialiang
    Guo, Chang
    Wang, Jiexiao
    Zhang, Xiaopeng
    Qi, Jian
    Huang, Xiang
    Hu, Zongtao
    Wang, Hongzhi
    Hong, Bo
    CANCER CONTROL, 2025, 32
12345